STOCK TITAN

Xcel Brands and ASP Isotopes Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
RedChip Companies will air interviews with Xcel Brands, Inc. (NASDAQ:XELB) and ASP Isotopes, Inc. (NASDAQ:ASPI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, January 13, at 7 p.m. Eastern Time (ET). Xcel Brands expects to generate $18 million in top-line royalty revenue in 2024 and is trading for a greater than 75% discount to its intrinsic value. ASP Isotopes has secured multiple supply agreements and was initiated with a buy rating and $3.25 per share price target by HC Wainwright.
Positive
  • Xcel Brands expects to generate $18 million in top-line royalty revenue in 2024.
  • Xcel Brands is trading for a greater than 75% discount to its intrinsic value.
  • ASP Isotopes has secured multiple supply agreements.
  • ASP Isotopes was initiated with a buy rating and $3.25 per share price target by HC Wainwright.
Negative
  • None.

Insights

Examining the broadcast of interviews with Xcel Brands and ASP Isotopes on Bloomberg TV, it's evident that Xcel Brands is leveraging the rapidly growing social commerce sector, which is anticipated to constitute 20% of U.S. online sales by 2026. The company's innovative model and proprietary platform, Orme, could significantly enhance its market position. The strategic sale of a major stake in one of its brands at a multiple of its royalty revenue suggests that Xcel Brands is optimizing its portfolio for financial efficiency and investor value. The claim of trading at a substantial discount to intrinsic value could attract investor interest, potentially affecting the stock's market performance.

ASP Isotopes' update suggests a strategic expansion into the production of non-nuclear enriched isotopes. The completion of its first plant and the establishment of offtake agreements indicate a move towards revenue generation. The long-term supply contracts and the prepayment from a U.S. customer reflect confidence in ASP's capabilities and future market position. The company's focus on securing 'take or pay' contracts could provide stable and predictable cash flows, which are crucial for assessing the company's financial health and future growth prospects in the eyes of investors.

Xcel Brands' financial resilience is highlighted by its positive adjusted EBITDA pre-COVID and its expected top-line royalty revenue for 2024. The company's working capital-light business model and the management team's significant shareholding align interests with external shareholders, potentially leading to prudent management decisions. The discount to intrinsic value mentioned could signal a potential undervaluation, which may warrant a closer look by investors seeking growth opportunities in emerging markets.

For ASP Isotopes, financial analysis of the supply agreements and the prepayment for future deliveries indicate a strong forward-looking revenue stream. The initiation of coverage by HC Wainwright with a buy rating and a specific price target provides an external validation of ASP's financial prospects. The company's strategic moves to secure long-term supply agreements and MOUs for HALEU, coupled with the expected demand, suggest a robust growth trajectory and the potential for significant market capture.

ASP Isotopes' acquisition of the ASP plants and the successful navigation of regulatory approvals from nuclear authorities, including the Non-proliferation Council of South Africa, demonstrate the company's capability to manage complex legal and regulatory environments. This is a fundamental aspect for companies operating within highly regulated industries, as it can significantly affect the timeline of revenue generation and market entry. The legal framework surrounding 'take or pay' contracts can also provide financial stability and reduce risk for the company, which is an important consideration for stakeholders evaluating long-term commitments.

ORLANDO, FL / ACCESSWIRE / January 12, 2024 / RedChip Companies will air interviews with Xcel Brands, Inc. (NASDAQ:XELB) and ASP Isotopes, Inc. (NASDAQ:ASPI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, January 13, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

Access the interviews in their entirety at:

In an exclusive interview, Robert D'Loren, Chairman and CEO of Xcel Brands, appears on the RedChip Small Stocks Big Money® Show on Bloomberg TV to provide a corporate update. Xcel Brands is a pioneering force in the convergence of shopping, entertainment, and social media and expects to generate $18 million in top-line royalty revenue in 2024. Based on the recent sale of 70% interest in its Isaac Mizrahi brand, which sold for six times royalty revenue, Xcel is trading for a greater than 75% discount to its intrinsic value, presenting tremendous potential upside for investors. Social commerce is expected to drive 20% of all US online sales by 2026, and Xcel is perfectly positioned to capture a significant market share with its proven approach to increasing conversion rates that significantly outperforms traditional digital marketing strategies. The Company's brands boast over 5 million social followers, generate over $600 million in annual retail sales, and have delivered over 20,000 hours of live-stream programming. Operating on a working capital-light business model, Xcel has a historical track record of revenue growth with positive adjusted EBITDA (pre-COVID), allowing for continued investment in brand and technology development. With the launch of its new proprietary live stream and social commerce platform, Orme, Xcel is set for strong cash flow generation starting in Q1 2024. The Company's management team, which holds over 60% of Xcel's outstanding shares, brings decades of experience in building major brand management companies, and they are committed to driving innovation and profitability. In summary, Xcel presents a unique investment opportunity, combining leadership in an emerging industry, innovative technology, creative excellence, financial resilience, and strong growth prospects.

Paul Mann, CEO of ASP Isotopes, appears on the RedChip Small Stocks Big Money® Show on Bloomberg TV to provide a corporate update. ASP Isotopes successfully acquired two incomplete ASP plants in Pretoria, South Africa, and obtained the required licenses from the nuclear regulators, including the Non-proliferation Council of South Africa, to complete construction of the plants and produce commercial product. Cold commissioning of the first manufacturing plant, capable of enriching light isotopes, was completed in Q1 2023, and ASP Isotopes entered into a Memorandum of Understanding with a North American customer for the entire offtake of the Company's first light isotope plant. The Company intends to enter into "take or pay" style offtake agreements with customers and expects to be a leading supplier of non-nuclear enriched isotopes by 2028. ASP Isotopes has secured multiple supply agreements, including a 25-year agreement valued at up to $27 million per annum with BRICEM (Beijing Research Institute of Chemical Engineering Metallurgy) to supply highly enriched Molybdenum-100 (Mo-100); a multi-year agreement with a Canadian company valued at $3.8 million per annum for Carbon-14 (C-14), the most frequently used radiolabel healthcare; a $9 million supply agreement with a US customer for a highly enriched isotope - customer made a $900,000 prepayment during Q3 2023 with commercial deliveries anticipated beginning in Q1 2024; and two MOUs for High Assay Low Enriched Uranium (HALEU) - $30 billion of HALEU demand expected based on initial discussions with customers. HC Wainwright initiated coverage of ASP Isotopes in December 2023 with a buy rating and $3.25 per share price target.

About Xcel Brands

Xcel Brands, Inc. (NASDAQ: XELB) is a media and consumer products company engaged in the design, production, marketing, live streaming, social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as one thing. Xcel owns the Judith Ripka, Halston, LOGO by Lori Goldstein, and C. Wonder by Christian Siriano brands and a minority stake in the Isaac Mizrahi brand. It also owns and manages the Longaberger brand through its controlling interest in Longaberger Licensing LLC. Xcel is pioneering a true modern consumer products sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, brick-and-mortar retail, and e-commerce channels to be everywhere its customers shop. The company's brands have generated in excess of $4 billion in retail sales via livestreaming in interactive television and digital channels alone. Headquartered in New York City, Xcel Brands is led by an executive team with significant live streaming, production, merchandising, design, marketing, retailing, and licensing experience, and a proven track record of success in elevating branded consumer products companies. www.xcelbrands.com.

About ASP Isotopes

ASP Isotopes Inc. is a pre-commercial stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process ("ASP technology"). The Company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes).

There is a growing demand for isotopes such as Silicon-28, which will enable quantum computing, and Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, and Uranium-235 for green energy applications. The ASP Technology (Aerodynamic Separation Process) is ideal for enriching low and heavy atomic mass molecules. For more information, please visit www.aspisotopes.com.

About RedChip Companies

RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 30 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, the RedChip Small Stocks Big Money® Show is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, "The RedChip Small Stocks Big Money® Show," which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.

To learn more about RedChip's products and services, please visit:

https://www.redchip.com/corporate/investor_relations

"Discovering Tomorrow's Blue Chips Today"™

Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

Follow RedChip on Twitter: https://twitter.com/RedChip

Follow RedChip on YouTube: https://www.youtube.com/@redchip

Follow RedChip on Rumble: https://rumble.com/c/c-3068340

Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

Contact:

Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
info@redchip.com

SOURCE: RedChip



View the original press release on accesswire.com

FAQ

What time will the interviews with Xcel Brands, Inc. and ASP Isotopes, Inc. air on Bloomberg TV?

The interviews will air on Bloomberg TV on Saturday, January 13, at 7 p.m. Eastern Time (ET).

What is the ticker symbol for Xcel Brands, Inc.?

The ticker symbol for Xcel Brands, Inc. is XELB.

What is the estimated top-line royalty revenue Xcel Brands, Inc. expects to generate in 2024?

Xcel Brands, Inc. expects to generate $18 million in top-line royalty revenue in 2024.

What is the discount to its intrinsic value at which Xcel Brands, Inc. is trading?

Xcel Brands, Inc. is trading for a greater than 75% discount to its intrinsic value.

What is the ticker symbol for ASP Isotopes, Inc.?

The ticker symbol for ASP Isotopes, Inc. is ASPI.

Who initiated coverage of ASP Isotopes, Inc. with a buy rating and what is the price target?

HC Wainwright initiated coverage of ASP Isotopes, Inc. with a buy rating and a $3.25 per share price target.

XCEL BRANDS INC.

NASDAQ:XELB

XELB Rankings

XELB Latest News

XELB Stock Data

11.34M
13.92M
40.97%
26.51%
0.38%
Apparel Manufacturing
Patent Owners & Lessors
Link
United States of America
NEW YORK